<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:chebi fb="56" ids="16716">Benzene</z:chebi> at high concentrations is known to cause <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), but its relationship with other lymphohematopoietic (LH) <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> remains uncertain, particularly at low concentrations </plain></SENT>
<SENT sid="1" pm="."><plain>In this pooled analysis, we examined the risk of five LH <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> relative to lower levels of <z:chebi fb="56" ids="16716">benzene</z:chebi> exposure in petroleum workers </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We updated three nested case-control studies from Australia, Canada, and the United Kingdom with new incident LH <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> among petroleum distribution workers through December 31, 2006, and pooled 370 potential case subjects and 1587 matched LH <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-free control subjects </plain></SENT>
<SENT sid="3" pm="."><plain>Quantitative <z:chebi fb="56" ids="16716">benzene</z:chebi> exposure in parts per million (ppm) was blindly reconstructed using historical monitoring data, and exposure certainty was scored as high, medium, or low </plain></SENT>
<SENT sid="4" pm="."><plain>Two hematopathologists assigned diagnoses and scored the certainty of diagnosis as high, medium, or low </plain></SENT>
<SENT sid="5" pm="."><plain>Dose-response relationships were examined for five LH <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, including the three most common <z:hpo ids='HP_0001909'>leukemia</z:hpo> cell-types (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> [<z:mp ids='MP_0005481'>CML</z:mp>], and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005526'>lymphoid leukemia</z:hpo> [CLL]) and two <z:e sem="disease" ids="C0027022" disease_type="Neoplastic Process" abbrv="MPD">myeloid tumors</z:e> (<z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> [<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>] and <z:mpath ids='MPATH_512'>myeloproliferative disease</z:mpath> [<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e>]) </plain></SENT>
<SENT sid="6" pm="."><plain>Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using conditional logistic regression, controlling for age, sex, and time period </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Cumulative <z:chebi fb="56" ids="16716">benzene</z:chebi> exposure showed a monotonic dose-response relationship with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (highest vs lowest tertile, &gt;2.93 vs â‰¤0.348 ppm-years, OR = 4.33, 95% CI = 1.31 to 14.3) </plain></SENT>
<SENT sid="8" pm="."><plain>For peak benezene exposures (&gt;3 ppm), the risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> was increased in high and medium certainty diagnoses (peak exposure vs no peak exposure, OR = 6.32, 95% CI = 1.32 to 30.2) and in workers having the highest exposure certainty (peak exposure vs no peak exposure, OR = 5.74, 95% CI = 1.05 to 31.2) </plain></SENT>
<SENT sid="9" pm="."><plain>There was little evidence of dose-response relationships for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, CLL, <z:mp ids='MP_0005481'>CML</z:mp>, or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Relatively low-level exposure to <z:chebi fb="56" ids="16716">benzene</z:chebi> experienced by petroleum distribution workers was associated with an increased risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, but not <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, suggesting that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> may be the more relevant health risk for lower exposures </plain></SENT>
</text></document>